Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2025-12-25 @ 2:30 AM
NCT ID:
NCT04013334
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed locally advanced or metastatic pleural mesothelioma
* Failed one prior treatment regimen including cisplatin-based chemotherapy
* Eastern cooperative oncology group (ECOG) performance status; 0,1
* Adequate organ function
* Measurable disease per RECIST
Exclusion Criteria:
* Candidate for surgical resection
* has active autoimmune disease, primary or acquired immunodeficiency
* significant cardiovascular disease
* has active interstitial lung disease
* has active infection or HIV, hepatitis B or C
* previous anti-PD-1, PD-L1 or CTLA-4 inhibitor immunotherapy
* other clinical significant disorder that could affect conduct of study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04013334
Study Brief:
Protocol Section:
NCT04013334